Metagenomi Therapeutics Statistics
NASDAQ: MGXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.565-0.0488 (-7.95%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Metagenomi Therapeutics by the numbers
Metagenomi Therapeutics has a market capitalization of $21.4 million based on 37.81M shares outstanding. With trailing EPS of $-2.50, Metagenomi Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 37.1% below its 50-day average and 53.9% below its 200-day average.
Average daily trading volume is 163.21K shares, or about $92,216 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MGX valuation vs. peer median
| Metric | MGX | Peer median | Difference |
|---|---|---|---|
| Market cap | $21.36M | $24.77M | -14% |
| Avg. volume | 163.21K | 140.19K | +16% |
Peer median across 8 companies: CVM, EVAX, SAEN, PTHS, INMB, LONA, EXOZ, ESLA.
Valuation
- Market cap
- $21.36M
- Price / sales (latest FY)
- 0.85
- EPS (TTM)
- $-2.50
- Shares outstanding
- 37.81M
Price and trading
- Previous close
- 0.6138
- Open
- 0.6162
- Day range
- 0.5621 – 0.618
- 52-week range
- 0.562 – 1.87
- 52-week change
- -62.58%
- 50-day moving average
- 0.8979
- Beta
- —
- Volume
- 274.38K
- Average volume
- 163.21K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 13, 2025
Additional statistics
- Market Cap
- 21.36M
- Forward Pe
- -0.29
- Eps
- -2.50
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.87
- Week52 Low
- 0.56
- Avg Volume
- 163.21K
- Shares Outstanding
- 37.81M
- Ma50
- 0.90
- Ma200
- 1.23
- Earnings Date
- Aug 13, 2025
- Pct From52w High
- -69.79%
- Pct From52w Low
- 0.53%